RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Choroidal Neovascularization
Accession: DOID:9001044
browse the term
Definition: A pathological process consisting of the formation of new blood vessels in the CHOROID.
Synonyms: exact_synonym: Choroid Neovascularization; Choroid Neovascularizations; Choroidal Neovascularizations
primary_id: MESH:D020256 ; RDO:0007376
For additional species annotation, visit the
Alliance of Genome Resources .
G
Adipoq
adiponectin, C1Q and collagen domain containing
treatment
ISO IDA IEP
RGD
PMID:17466298 , PMID:22633972 , PMID:16689928
RGD:8694464 , RGD:8695931 , RGD:2289282
NCBI chr11:81,330,845...81,344,488
Ensembl chr11:81,330,293...81,344,488
G
Aoc3
amine oxidase, copper containing 3
IMP
RGD
PMID:18436961
RGD:2313908
NCBI chr10:89,251,370...89,259,313
Ensembl chr10:89,251,370...89,259,313
G
Bmp4
bone morphogenetic protein 4
ISO
RGD
PMID:21411747 , PMID:22392094
RGD:8699493 , RGD:8699501
NCBI chr15:20,776,060...20,791,013
Ensembl chr15:20,776,054...20,822,740
G
C5
complement C5
ISO
RGD
PMID:16849499
RGD:7411733
NCBI chr 3:14,049,993...14,113,931 NCBI chr 3:14,206,466...14,229,141
Ensembl chr 3:14,049,995...14,229,080
G
Ccl2
C-C motif chemokine ligand 2
treatment
ISO
RGD
PMID:17389519
RGD:8548832
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
G
Ccr2
C-C motif chemokine receptor 2
ISO
RGD
PMID:22205983
RGD:8657364
G
Ccr3
C-C motif chemokine receptor 3
ISO
RGD
PMID:19525930
RGD:6893454
NCBI chr 8:133,026,539...133,040,999
Ensembl chr 8:133,029,625...133,040,997
G
Cfb
complement factor B
ISO
RGD
PMID:16849499
RGD:7411733
NCBI chr20:4,536,206...4,542,073
Ensembl chr20:4,536,203...4,561,066 Ensembl chr20:4,536,203...4,561,066
G
Cfh
complement factor H
treatment
ISO
DNA:SNPs:cds:p.Y402H,I62V(human) associated with myopia;DNA:SNP: :rs1061170(human)
RGD
PMID:23258212 , PMID:22536038 , PMID:22678500
RGD:7364943 , RGD:7365031 , RGD:7365030
NCBI chr13:56,979,155...57,080,540
Ensembl chr13:56,978,607...57,080,622
G
F7
coagulation factor VII
treatment
ISO
mouse protein in a rat model
RGD
PMID:19357351 , PMID:19357351
RGD:2312299 , RGD:2312299
NCBI chr16:81,824,610...81,834,923
Ensembl chr16:81,824,111...81,834,945
G
Fgf2
fibroblast growth factor 2
treatment
IEP
RGD
PMID:10359334
RGD:8655568
NCBI chr 2:124,081,072...124,134,133
Ensembl chr 2:124,081,072...124,134,681
G
Flt1
Fms related receptor tyrosine kinase 1
treatment
ISO IMP
RGD
PMID:10849558 , PMID:23804076 , PMID:23977149
RGD:10402112 , RGD:10402115 , RGD:10402113
NCBI chr12:9,033,993...9,205,886
Ensembl chr12:9,034,308...9,205,905
G
Hgf
hepatocyte growth factor
IEP
protein:increased expression:choroidal tissue:
RGD
PMID:19013152
RGD:8548599
NCBI chr 4:15,435,460...15,505,377
Ensembl chr 4:15,433,295...15,505,362
G
Htra1
HtrA serine peptidase 1
no_association
ISO
DNA:snp:promoter:g.-625G>A (rs11200638) (human) human gene in mouse model associated with Myopia; DNA:snp:promoter:g.-625G>A (rs11200638) (human)
RGD
PMID:18682806 , PMID:21844367 , PMID:19680273
RGD:7394694 , RGD:7394749 , RGD:7394720
NCBI chr 1:201,499,067...201,548,508
Ensembl chr 1:201,499,028...201,548,513
G
Icam1
intercellular adhesion molecule 1
IEP
mRNA:increased expression:retina, choroid, sclera (rat)
RGD
PMID:20497436
RGD:4145405
NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
G
Igf1r
insulin-like growth factor 1 receptor
treatment
ISO
RGD
PMID:19032681
RGD:10045869
NCBI chr 1:128,924,921...129,213,816
Ensembl chr 1:128,924,966...129,206,516
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
treatment
ISO
RGD
PMID:24489934
RGD:10045942
NCBI chr16:74,177,233...74,230,809
Ensembl chr16:74,177,215...74,230,815
G
Il10
interleukin 10
treatment
ISO
RGD
PMID:22802947 , PMID:16903779
RGD:7364853 , RGD:7365068
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
G
Il2
interleukin 2
treatment
ISO
associated with Macular Degeneration;protein:decreased expression:aqueous humor:
RGD
PMID:19262441
RGD:10047086
NCBI chr 2:123,847,150...123,851,854
Ensembl chr 2:123,847,150...123,851,854
G
Itgav
integrin subunit alpha V
IMP
RGD
PMID:15287373
RGD:1582458
NCBI chr 3:71,113,269...71,205,958
Ensembl chr 3:71,114,100...71,202,411
G
Jam3
junctional adhesion molecule 3
treatment
ISO
RGD
PMID:22323465
RGD:7488935
NCBI chr 8:28,147,110...28,208,466
Ensembl chr 8:28,147,111...28,208,466
G
Kdr
kinase insert domain receptor
treatment
ISO IDA IMP
RGD
PMID:19085383 , PMID:15249365 , PMID:18436847 , PMID:22997228 , PMID:12937991
RGD:8549713 , RGD:8549747 , RGD:8549741 , RGD:8549738 , RGD:8549716
NCBI chr14:34,727,677...34,787,127
Ensembl chr14:34,727,623...34,787,183
G
Lep
leptin
IEP
associated with Metabolic Syndrome X;mRNA:increased expression:retina (rat)
RGD
PMID:25380250
RGD:10053625
NCBI chr 4:56,337,695...56,351,818
Ensembl chr 4:56,337,695...56,351,818
G
Loxl1
lysyl oxidase-like 1
ISO
RGD
PMID:18296663
RGD:7394725
NCBI chr 8:63,067,757...63,092,124
Ensembl chr 8:63,067,300...63,092,009
G
Mmp13
matrix metallopeptidase 13
ISO
RGD
PMID:20700625 , PMID:20700625
RGD:10043118 , RGD:10043118
NCBI chr 8:5,522,739...5,533,018
Ensembl chr 8:5,522,739...5,533,018
G
Mmp2
matrix metallopeptidase 2
treatment
ISO IDA
RGD
PMID:21666238 , PMID:25314292
RGD:8657062 , RGD:13207327
NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
G
Mmp9
matrix metallopeptidase 9
treatment
ISO IDA
protein:increased expression:plasma
RGD
PMID:12368198 , PMID:25314292 , PMID:17304258
RGD:8547840 , RGD:13207327 , RGD:8657061
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
G
RT1-CE13
RT1 class I, locus CE13
susceptibility
ISO
associated with Macular Degeneration; DNA:polymorphisms:cds:HLA-B27 (human)
RGD
PMID:19728932
RGD:7365097
G
Serpinf1
serpin family F member 1
treatment
IEP ISO
human gene in a mouse model human protein in a rat model protein:increased expression:aqueous humor (human)
RGD
PMID:15312607 , PMID:12037010 , PMID:19778186 , PMID:19850839 , PMID:16490490 , PMID:11424092
RGD:2312356 , RGD:28867245 , RGD:27226711 , RGD:8655557 , RGD:8554883 , RGD:8554866
NCBI chr10:62,241,750...62,254,145
Ensembl chr10:62,241,756...62,254,287
G
Sod1
superoxide dismutase 1
ISO
RGD
PMID:16844785
RGD:1581207
NCBI chr11:30,363,282...30,368,858
Ensembl chr11:30,363,280...30,368,862
G
Stat3
signal transducer and activator of transcription 3
treatment
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:17525280 , PMID:23094067
RGD:8694307 , RGD:10403057
NCBI chr10:88,790,401...88,842,263
Ensembl chr10:88,790,408...88,842,233
G
Tlr2
toll-like receptor 2
ISO
associated with Chlamydophila Infections;
RGD
PMID:20393111
RGD:8552825
NCBI chr 2:182,840,171...182,846,061
Ensembl chr 2:182,840,727...182,846,061
G
Tymp
thymidine phosphorylase
IEP
RGD
PMID:12556409
RGD:2293727
NCBI chr 7:130,342,481...130,347,845
Ensembl chr 7:130,342,483...130,347,587
G
Tyr
tyrosinase
ISO
ClinVar Annotator: match by term: Choroidal neovascularization
ClinVar
PMID:666627 PMID:1429711 PMID:1820207 PMID:7704033 PMID:9158138 PMID:10766867 PMID:17952075 PMID:18326704 PMID:18488027 PMID:18488028 PMID:18925668 PMID:19208379 PMID:19533789 PMID:21541274 PMID:23504663 PMID:25216246 PMID:25741868
NCBI chr 1:151,012,598...151,106,802
Ensembl chr 1:151,012,598...151,106,802
G
Vegfa
vascular endothelial growth factor A
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism mRNA,protein:increased expression:choroidal tissue,retina:
CTD
PMID:16680105 , PMID:20237252 , PMID:19013152 , PMID:16723717
RGD:7483614 , RGD:8548599 , RGD:8548459
NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
G
Vegfb
vascular endothelial growth factor B
ISO
RGD
PMID:19369214
RGD:2314323
NCBI chr 1:222,237,000...222,242,786
Ensembl chr 1:222,239,022...222,242,644
G
Serpine1
serpin family E member 1
treatment severity
ISO IDA
mRNA:increased expression:retina (mouse) human gene in mouse model
RGD
PMID:12766088 , PMID:26610445 , PMID:11292663 , PMID:12766088
RGD:8547735 , RGD:11073722 , RGD:8547737 , RGD:8547735
NCBI chr12:22,641,104...22,651,482
Ensembl chr12:22,641,104...22,651,482
G
Smo
smoothened, frizzled class receptor
treatment
IMP
RGD
PMID:21063852
RGD:12859045
NCBI chr 4:57,019,941...57,041,779
Ensembl chr 4:57,019,941...57,042,770
G
C2
complement C2
susceptibility
ISO
DNA:SNP:intron:c.1360+62G>T (rs547154) (human)
RGD
PMID:22232432
RGD:7411694
NCBI chr20:4,542,340...4,561,152
Ensembl chr20:4,542,340...4,561,152
G
Cfb
complement factor B
susceptibility
ISO
DNA:snp:intron:c.1169-69T>C (rs541862) (human)
RGD
PMID:22232432
RGD:7411694
NCBI chr20:4,536,206...4,542,073
Ensembl chr20:4,536,203...4,561,066 Ensembl chr20:4,536,203...4,561,066
G
Cfh
complement factor H
susceptibility no_association
ISO
DNA:SNP, missense mutation:promoter, cds:g.-257C>T, p.I62V (rs3753394, rs800292) (human) DNA:missense mutation:cds:p.Y402H (rs1061170) (human)
RGD
PMID:18515590 , PMID:18515590
RGD:7411726 , RGD:7411726
NCBI chr13:56,979,155...57,080,540
Ensembl chr13:56,978,607...57,080,622
G
Crp
C-reactive protein
ISO
RGD
PMID:17400294
RGD:9491775
NCBI chr13:91,080,448...91,081,358
Ensembl chr13:91,054,974...91,093,713
G
Eln
elastin
susceptibility no_association
ISO
DNA:SNP,haplotype: :rs2301995(human) DNA:SNP: :rs2301995(human)
RGD
PMID:18326737 , PMID:21391811
RGD:9585729 , RGD:9585730
NCBI chr12:24,978,478...25,021,864
Ensembl chr12:24,978,483...25,021,863
G
Htra1
HtrA serine peptidase 1
susceptibility
ISO
human gene in mouse model DNA:snp:promoter:g.-625G>A (rs11200638) (human)
RGD
PMID:21844367 , PMID:23326481
RGD:7394749 , RGD:7394751
NCBI chr 1:201,499,067...201,548,508
Ensembl chr 1:201,499,028...201,548,513
G
Mmp2
matrix metallopeptidase 2
ISO
protein:increased expression:serum
RGD
PMID:23559867
RGD:8547885
NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
G
Mmp9
matrix metallopeptidase 9
ISO
protein:increased expression:serum
RGD
PMID:23559867
RGD:8547885
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
G
Vegfa
vascular endothelial growth factor A
susceptibility
ISO
DNA:SNP,haplotype: :rs833069(human)
RGD
PMID:22307775
RGD:7483605
NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all